🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2018-08-15
Trial ID
NCT03553940
Vaccines are used to prevent infectious diseases worldwide. Unfortunately, ...
Status
Completed
Location
Radboud University
Start Date
2021-09-20
Trial ID
NCT05082688
The purpose of this placebo controlled study is to evaluate the safety and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-09-25
Trial ID
NCT01949090
Treatments Being Tested
The aim of this study is to assess the immunogenicity, safety and reactogen...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-14
Trial ID
NCT05568797
Treatments Being Tested
This study may provide safety information on a flu vaccine given to childre...
Status
Completed
Location
UCLA Center For Vaccine Research
Start Date
2007-02
Trial ID
NCT00402649
Treatments Being Tested
The study is a single centre, phase I, open, randomized, by intranasal and ...
Status
Completed
Location
National Center for Tuberculosis Problems, Kazakhstan
Start Date
2013-10
Trial ID
NCT03017378
Treatments Being Tested
The aim of this study is to evaluate the safety and immunogenicity of Fluzo...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01946425
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety, and re...
Status
Completed
Location
Pinnacle Research Group-409 E 10th St
Start Date
2023-10-19
Trial ID
NCT06097273
Treatments Being Tested
This is a Phase Ib study in healthy adults (18-70 years) to evaluate the sa...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2012-08
Trial ID
NCT01676402
Treatments Being Tested